"Designing Growth Strategies is in our DNA"

Peritoneal Dialysis Market Size, Share and Global Trend By Product Type (CAPD, APD), Product (Cyclers, Fluids), End User (Home health care and Hospitals) and Geography Forecast till 2025

Region : Global | Latest Update: Jul, 2019 | Published Date: Apr, 2019 | Report ID: FBI100089| Status : Published



Global Peritoneal Dialysis Market Accounted for a Revenue of US$ 3,589.9 Mn in 2017, and is Expected to Reach US$ 6,077.2 Mn by the End of 2025, with a CAGR of 6.9%.

Peritoneal Dialysis (PD) is one of the fastest growing treatment options for kidney failures and is a better option especially for patients with residual kidney function and intolerance of rapid fluid balance changes associated with hemodialysis. PD offers treatment flexibility and reduces visits to dialysis centers. Choosing PD home dialysis provides benefits such as better results, lesser medications, and fewer food restriction.

Patients can use peritoneal dialysis at home without assistance and easily monitor 24/7. These advantages made PD more popular in kidney patients now a day, and will further fuel the growth of home care segment during the forecast period. Most of the end-stage renal disease patients undergoing PD treatment are elderly, and level of their accessibility, experience, and technical education differs widely. Technophobia and reluctance to use cyclers are considered to be challenging by many of the elderly cycler patients.

Get comprehensive study about this report by, request a sample copy

Automated Peritoneal Dialysis (APD) to Emerge as Most Attractive PD Type

Peritoneal Dialysis has been widely accepted as an effective form of renal replacement therapy for patients with end-stage renal disease. As per published NCBI article in 2015, the expert opinion concludes that around 60% of patients on PD in the U.S. opt for APD, compared to approximately 50% of PD patients in Europe opt APD. CAPD accounted for a major share of the global PD market in 2017. With the rise in popularity of the cycler, the percentage of patients on APD is trending upward. Recent advancements in the APD system and new product development with advanced technologies are expected to generate a huge demand for the automated peritoneal dialysis during 2018-2025.

To get details on market share, speak to our analyst

In terms of product, the fluids segment dominated the global peritoneal dialysis market in 2017. Fluids are used in both the type CAPD and APD, cost of fluids used in CAPD is higher than the APD which supports the growth of the overall segment in the global peritoneal devices market. Rising adoption of PD in emerging countries such as China, India, Brazil, etc. expected to create higher demand for fluids, driving the growth of the segment during the forecast period. Faster adoption of new technologies in developed countries is one of the major cause supporting the growth of cyclers segment. Advantages of APD over CAPD is expected to generate higher demand of APD cyclers which will further support the growth of the overall market during the forecast period.

Shift from In-center Dialysis to Home Dialysis Enables Market Exhibit Highest CAGR in the Asia Pacific

Asia Pacific region generated revenue of US$ 1,194.1 Mn in 2017 and is anticipated to hold a significant share in the global PD market during the forecast period. Growth witnessed in the region is created by a huge prevalence of PD patients, rising adoption of PD in end-stage renal disease patients, increasing government support and adequate reimbursement policies. Major players such as Baxter adheres to the business expansion policies in emerging countries such as China, and India. This would further drive the market during the forecast period. However, the peritoneal dialysis market in North America is expected to expand at a relatively lower CAGR during 2018-2025, which is attributable to the smaller patient pool as compared to Asia Pacific region, though North America holds significant market share owing to highest adoption of APD across the globe.

Asia Pacific Peritoneal Dialysis Market, 2017

To get geographical overview of this market, request a sample copy

Baxter & Fresenius Kabi AG to Account for More Than Half of the Market Share in Terms of Revenue

Baxter emerged as a leading player with the highest market share in 2017, as the company is engaged in realigning its diversification strategy to improve the accessibility of its key brands. A diversified product portfolio, established brand presence, and strong research and development (R&D) focus in the peritoneal devices market are responsible for strong brand position in the market. The company also has a strong presence across the globe, through a network of distributors and subsidiaries in the Asia Pacific, Latin America, and Africa.


Due to increasing awareness of peritoneal dialysis as a treatment option, there is rising demand from the patients for newer product launches with advanced technologies, that suit the individual patient’s requirements. Compared to home hemodialysis, peritoneal dialysis at home is cost effective and also technically less challenging which supports the growth of the PD market during the forecast period.

The report provides qualitative and quantitative insights on the PD market and detailed analysis of market size and growth rate for all possible segments in the market. The market is segmented by type, product, and end users. By type, the global PD market is categorized CAPD (continuous ambulatory peritoneal dialysis) and APD (automated peritoneal dialysis). Based on the product, the global PD market is segmented into cyclers and fluids and other accessories. Various end users covered in the report are home health care, and hospital & others. Geographically, the market is segmented into five major regions which are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions are further categorized into countries.

Along with this, the report provides elaborative analysis of market dynamics and competitive landscape. Various key insights provided in the report are the prevalence of end-stage renal disease and chronic kidney disease, recent industry developments such as mergers & acquisitions, overview of major dialysis services providers, estimated number of patients on HD (hemodialysis) vs PD (2017), reimbursement scenario, number of nephrologists (2016) and key industry trends.


To get information on various segments, share your queries with us




By Type



By Product

· Cyclers

· Fluids

· Other Accessories

By End User

· Home health care

· Hospitals and Others

By Geography

· North America (USA and Canada)

· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

· Latin America (Brazil, Mexico and Rest of Latin America)

· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)


  • Baxter International Inc.
  • Fresenius Kabi AG
  • Medtronic
  • Utah Medical Products, Inc.
  • Glomeria Therapeutics
  • Poly Medicure Ltd.
  • Cook Medical Inc.
  • CardioMed Supplies Inc.
  • Medical Components, Inc.
  • Other players

Key Industry Developments

  • In January 2019, AWAK Technologies received FDA breakthrough designation for the company’s Peritoneal Dialysis Mix device, a wearable dialysis device used for patients suffering from kidney disease.
  • In December 2017, Zytoprotec received Orphan Drug Designation from the U.S FDA for the company’s novel Dialysis Fluid indicated to be used in peritoneal dialysis.
  • In October 2015, the U.S FDA approved Baxter’s AMIA automated home peritoneal dialysis (APD) system.

Peritoneal Dialysis Market Size, Share and Global Industry Trend Forecast till 2026
  • PDF
  • 2017
  • 2014-2016
  • 135


  • 4850
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.